Preskoči na vsebino
HPB-ALL
Tkivo
Peripheral blood
Bolezen
Precursor T-cell acute lymphoblastic leukemia
Mesto metastaze
Peripheral blood (systemic T-ALL)
Sinonimi
HPB/ALL, HPBALL, FCCH1018

Dokumenti

HPB-ALL

Cell line · Številka izdelka 302895

HPB-ALL je celična linija akutne limfoblastne levkemije iz predhodnih T-celic (T-ALL) pri človeku, vzpostavljena iz periferne krvi 14-letnega japonskega dečka...

€430.00brez davka in stroškov poštnine

Prilagajanje / Priporočila

Na zalogi
Lot
Priporočeno (najsvežja pošiljka)
  • CoA
1

01Splošne informacije

Opis

HPB-ALL is a human precursor T-cell acute lymphoblastic leukemia (T-ALL) cell line established from the peripheral blood of a 14-year-old Japanese male patient. The line grows in suspension with lymphocyte-like morphology. HPB-ALL harbors a complex TP53 mutational profile with eight mutations across heterozygous and homozygous states, reflecting the genetic complexity of T-ALL at diagnosis. The line expresses T cell surface markers consistent with T-ALL biology, making it relevant for studies of T lymphoblast leukemia pathogenesis and drug responses.

HPB-ALL is applicable in studies of T-ALL biology, TP53 multi-mutant phenotype, anti-leukemic drug sensitivity (glucocorticoids, vincristine, asparaginase, nelarabine), Notch and JAK-STAT pathway analysis, and comparative studies within the T-ALL cell line panel. It is suitable for in vitro pharmacological assays and xenograft models in immunocompromised hosts for preclinical T-ALL drug evaluation. Doubling time approximately 50 hours.

Tkivo
Peripheral blood
Bolezen
Precursor T-cell acute lymphoblastic leukemia
Mesto metastaze
Peripheral blood (systemic T-ALL)
Uporaba
T-ALL biology; TP53 multi-mutant phenotype; anti-leukemic drug sensitivity (glucocorticoids, vincristine, asparaginase, nelarabine); Notch/JAK-STAT pathways; xenograft models; T-ALL panel comparative studies
Sinonimi
  • HPB/ALL
  • HPBALL
  • FCCH1018

02Razvrstitev

Organizem
Človek
Seks
Moški
Lastnosti rasti
Vzmetenje
Stopnja biološke varnosti
1

03Značilnosti

Morfologija
Lymphoblast-like
Vrsta celice
T-cell
Čas podvojitve
~50 hours

04Identifikatorji

Navajanje vira
HPB-ALL (Cytion catalog number 302895)
Davčna identifikacijska številka NCBI
9606
Cellosaurus
CVCL_1820

05Izražanje in dovzetnost

Profil mutacij
Mutation: p.Arg465His, Unspecified; Mutation: p.Ala134Ser, Unspecified; Mutation: p.Leu1574Pro, Heterozygous; Mutation: p.Asp2442fs*39, Heterozygous; Mutation: p.Arg159Ser, Unspecified; Mutation: p.Cys124Ter, Homozygous; Mutation: p.Arg273Cys, Unspecified; Mutation: p.Ser121Ter, Unspecified

06Ravnanje in gojenje

Gojišče
RPMI 1640, w: 2.0 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
Prehranska dopolnila
Supplement the medium with 10% FBS
Reagenca za disociacijo
dilution
Preusmeritev v drugo kulturo
Dilute the culture to 2–5 × 10⁵ cells/ml with fresh pre-warmed complete medium twice per week. No enzymatic dissociation required.
Razmerje delitve
1 : 10 split
Gostota setve
3-5*10^5/ml
Obnova tekočine
Subculture : 2 times/week
Odtaljevanje in gojenje
  1. Confirm that the vial remains deeply frozen upon delivery, as cells are shipped on dry ice to maintain optimal temperatures during transit.

  2. Upon receipt, either store the cryovial immediately at temperatures below -150°C to ensure the preservation of cellular integrity, or proceed to step 3 if immediate culturing is required.

  3. For immediate culturing, swiftly thaw the vial by immersing it in a 37°C water bath with clean water and an antimicrobial agent, agitating gently for 40-60 seconds until a small ice clump remains.

  4. Perform all subsequent steps under sterile conditions in a flow hood, disinfecting the cryovial with 70% ethanol before opening.

  5. Carefully open the disinfected vial and transfer the cell suspension into a 15 ml centrifuge tube containing 8 ml of room-temperature culture medium, mixing gently.

  6. Centrifuge the mixture at 200 x g for 5 minutes, carefully discard the supernatant containing freezing medium.

  7. Follow the procedure described under Post-Thaw Recovery

07Kontrola kakovosti in krioprezervacija

Medij za zamrzovanje
As a cryopreservation medium, we use complete growth medium + 10% DMSO for adequate post-thaw viability.
Pogoji shranjevanja

For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen.

Pogoji dostave

Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage.

08Donator

Starost darovalca
14 years
Etnična pripadnost
Japanese

10Podrobnosti o izdelku

Tabela sestave